8 Articles
8 Articles
Merck collaborates with Mayo Clinic to support AI-enabled drug discovery and development
Rahway-based Merck and Mayo Clinic, the world’s top-ranked hospital system, have announced a research and development agreement to apply artificial intelligence (AI), advanced analytics and multimodal clinical data to support drug discovery and development. The agreement integrates Mayo Clinic’s Platform architecture as well as clinical and genomic datasets with Merck’s ambition to harness AI-enabled virtual cell technologies to enhance disease …
MSD and Mayo Clinic team up to advance AI in drug development
MSD and Mayo Clinic have entered a R&D collaboration to use AI, advanced analytics, and clinical data in support of drug discovery and precision medicine.The post MSD and Mayo Clinic team up to advance AI in drug development appeared first on Hospital Management.
Merck Mayo AI Partnership Aims To Sharpen Drug Discovery Decisions
Merck (NYSE:MRK) and Mayo Clinic announced a new research and development partnership focused on using artificial intelligence and multimodal clinical data for drug discovery and development. The collaboration combines Mayo Clinic's large clinical and genomic datasets with Merck's AI driven virtual cell technologies to support earlier stage drug research. Mayo Clinic characterized this as its largest collaboration with a global biopharmaceutical…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

